↓ Skip to main content

Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter
1 tweeter
patent
2 patents

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
Published in
Journal for Immunotherapy of Cancer, June 2014
DOI 10.1186/2051-1426-2-17
Pubmed ID
Authors

Mizuki Nishino, Maria Gargano, Margaret Suda, Nikhil H Ramaiya, F Stephen Hodi

Abstract

Investigate the impact of the reduction of the number of target lesions on immune-related response assessment in advanced melanoma patients treated with ipilimumab.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 59 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 28%
Other 8 13%
Student > Ph. D. Student 6 10%
Student > Postgraduate 5 8%
Student > Doctoral Student 3 5%
Other 10 17%
Unknown 11 18%
Readers by discipline Count As %
Medicine and Dentistry 30 50%
Agricultural and Biological Sciences 6 10%
Biochemistry, Genetics and Molecular Biology 2 3%
Neuroscience 2 3%
Immunology and Microbiology 2 3%
Other 3 5%
Unknown 15 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2018.
All research outputs
#4,864,050
of 17,353,889 outputs
Outputs from Journal for Immunotherapy of Cancer
#831
of 1,739 outputs
Outputs of similar age
#51,904
of 201,229 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 1 outputs
Altmetric has tracked 17,353,889 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,739 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them